Literature DB >> 16549462

Fish oil increases bile acid synthesis in male patients with hypertriglyceridemia.

Iris J A M Jonkers1, Augustinus H M Smelt, Hans M G Princen, Folkert Kuipers, Johannes A Romijn, Renze Boverhof, Ad A M Masclee, Frans Stellaard.   

Abstract

Fibrates are drugs of choice in patients with hypertriglyceridemia (HTG), but may increase the risk for gallstones by decreasing bile acid synthesis. Fish oil might be a therapeutic alternative, but its effect on bile acid metabolism in humans is unknown. We compared the effects of triglyceride-lowering therapy by fish oil or bezafibrate on cholesterol synthesis and bile acid metabolism in HTG. Cholesterol synthesis, bile acid pool sizes, and synthesis rates were compared between 9 male HTG patients and 10 normolipidemic controls matched for age, sex, and BMI. Effects of bezafibrate or fish oil were studied only in HTG patients in a randomized crossover trial. Patients had 14-fold higher serum triglyceride concentrations and greater cholesterol synthesis, as indicated by a 107% higher ratio of serum lathosterol to cholesterol (P < 0.01) than controls. The groups did not differ in bile acid metabolism. Both bezafibrate and fish oil reduced serum TG concentration (-68 and -51% vs. baseline, respectively). Compared with baseline, bezafibrate therapy was associated with reduced cholesterol synthesis (-25%, P = 0.009) without changes in bile acid synthesis rate and pool size. In contrast, fish oil increased bile acid synthesis (+31% vs. baseline, P = 0.07 and +53% vs. bezafibrate, P = 0.02) and altered bile acid distribution, as reflected by an increased ratio of the cholic acid (CA) synthesis rate to the chenodeoxycholic acid (CDCA) synthesis rate (+35% vs baseline, P = 0.05 and + 32% vs bezafibrate, P = 0.07) without effects on bile acid pool size or cholesterol synthesis. In conclusion, cholesterol synthesis is greater in HTG patients than in controls, whereas bile acid synthesis does not differ. Bezafibrate and fish oil have similar triglyceride-lowering capacities, but distinct effects on cholesterol synthesis. Bile acid synthesis is increased by fish oil, but not by bezafibrate therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16549462     DOI: 10.1093/jn/136.4.987

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  10 in total

Review 1.  Identification and treatment of metabolic complications in pediatric obesity.

Authors:  Katie Larson Ode; Brigitte I Frohnert; Brandon M Nathan
Journal:  Rev Endocr Metab Disord       Date:  2009-09       Impact factor: 6.514

2.  Dietary fish oil increases fat absorption and fecal bile acid content without altering bile acid synthesis in 20-d-old weanling rats following massive ileocecal resection.

Authors:  Qing Yang; Tian Lan; Yuegang Chen; Paul A Dawson
Journal:  Pediatr Res       Date:  2012-03-23       Impact factor: 3.756

Review 3.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

Review 4.  Advances in understanding of bile acid diarrhea.

Authors:  Michael Camilleri
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-11-25       Impact factor: 3.869

5.  Dietary fish oil exerts hypolipidemic effects in lean and insulin sensitizing effects in obese LDLR-/- mice.

Authors:  Viswanathan Saraswathi; Jason D Morrow; Alyssa H Hasty
Journal:  J Nutr       Date:  2009-10-28       Impact factor: 4.798

6.  Prevention of gallbladder hypomotility via FATP2 inhibition protects from lithogenic diet-induced cholelithiasis.

Authors:  Kevin M Tharp; Amin Khalifeh-Soltani; Hyo Min Park; David A Yurek; Alaric Falcon; Louis Wong; Rouying Feng; Kamran Atabai; Andreas Stahl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-31       Impact factor: 4.052

Review 7.  Beyond intestinal soap--bile acids in metabolic control.

Authors:  Folkert Kuipers; Vincent W Bloks; Albert K Groen
Journal:  Nat Rev Endocrinol       Date:  2014-05-13       Impact factor: 43.330

8.  Lipid and phospholipid profiling of biological samples using MALDI Fourier transform mass spectrometry.

Authors:  S Mariccor A B Batoy; Sabine Borgmann; Karin Flick; Josephine Griffith; Jeffrey J Jones; Viswanathan Saraswathi; Alyssa H Hasty; Peter Kaiser; Charles L Wilkins
Journal:  Lipids       Date:  2008-11-13       Impact factor: 1.880

9.  Use of Omega-3 Polyunsaturated Fatty Acids to Treat Inspissated Bile Syndrome: A Case Report.

Authors:  Woo Young Jun; Min Jeng Cho; Hye Seung Han; Sun Hwan Bae
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2016-12-28

10.  Omega 3 fatty acids promote macrophage reverse cholesterol transport in hamster fed high fat diet.

Authors:  Fatima Kasbi Chadli; Hassane Nazih; Michel Krempf; Patrick Nguyen; Khadija Ouguerram
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.